To determine the role of magnetic resonance cholangiopancreatography (MRCP) in evaluation of choledocholithiasis in patients with suspected cholecystitis. Materials and Methods: A total of 78 patients (mean age: 66.06 ± 15.63 years; range: 21-94 years, Male:Female = 31:47) who had experienced symptoms of cholecystitis and who underwent computed tomography (CT), MRCP, and endoscopic retrograde cholangiopancreatography from January 2013 to February 2015 were included in this study. Two reviewers independently interpreted CT and MRCP images to determine the presence or absence of choledocholithiasis and cholelithiasis. Diagnostic performance (sensitivity, specificity, positive predictive value, negative predictive value, and accuracy) was compared between CT and MRCP. Interobserver agreement was also evaluated. Results: Forty-three patients underwent cholecystectomy. The accuracy of CT and MRCP for detection of gallbladder stones showed no significant difference. The sensitivity and accuracy of MRCP for detection of extrahepatic duct stones were superior to those of CT for both reviewers (reviewer 1: MRCP: sensitivity, 73.3%; accuracy, 76.9%; CT: sensitivity, 50%, accuracy 59%; p = 0.01; reviewer 2: MRCP: sensitivity, 75%; accuracy, 73.1%; CT: sensitivity, 50%; accuracy, 56.4%; p = 0.018). The interobserver agreement was consistent for both CT (k-value: 0.738) and MRCP (k-value: 0.701). Conclusion: MRCP showed superior diagnostic performance for the detection of choledocholithiasis with reliable interobserver agreement. Considering the lack of radiation and contrast enhancement, MRCP would be an appropriate first-line modality in evaluation of common bile duct stones in patients with suspected cholecystitis. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
Choledocholithiasis may be associated with approximately 10-20% of patients with symptomatic gallstones (1) . Although 5-5% of common bile duct (CBD) stones may be asymptomatic, residual CBD stones post-cholecystectomy may cause potential complications including postoperative biliary leakage, re-current biliary colic, cholangitis and pancreatitis. These conditions are associated with major morbidity and mortality (2) . Therefore, it is mandatory for clinicians to identify and treat choledo- dex (elevated bilirubin and alkaline phosphatase levels), and imaging data obtained using abdominal ultrasonography (US) or computed tomography (CT) (1, 3) . These indicators may be affected by other factors and none of them show conclusive diagnostic accuracy for CBD stones. Although detection of gallstones is over 95% accurate using US, detection sensitivity for choledocholithiasis varies between 50-80%. In addition, the accuracy for early detection of extrahepatic obstruction is low (3, 4) . Both CT and US infrequently provide sufficient detailed anatomical information of the biliary tract, which is necessary for surgical interventions (5) .
Magnetic resonance cholangiopancreatography (MRCP) is a non-invasive technique that can be performed rapidly without exposing patients to ionizing radiation or iodinated contrast materials (1) . MRCP displays superior soft tissue resolution and possesses significant accuracy in the diagnosis of choledocholithiasis (1, 4) . It has evolved as an alternative or complementary method to endoscopic retrograde cholangiopancreatography (ERCP) in the diagnosis of patients with choledocholithiasis (5, 6) .
However, its cost-effectiveness is under debate; the indication of MRCP for preoperative evaluation of choledocholithiasis remains unclear.
The purpose of this study was to compare the diagnostic performance of CT and MRCP for the detection of CBD stones in patients with suspected cholecystitis and therefore, to determine the role of MRCP as a preoperative first-line imaging modality for the evaluation of choledocholithiasis.
MaTERIaLS aND METhODS

Patients
The study protocol was approved by the Institutional Review Board and the need for written informed consent was waived (EMCIRB [16] [17] [18] [19] . From January 2013 through February 2015, consecutive patients who underwent MRCP without enhancement for suspected cholecystitis were identified retrospectively.
The diagnosis of cholecystitis was based on Tokyo guidelines 2013 (7) . Patients who underwent preoperative CT and ERCP as a reference standard were included.
Among the 313 patients, the following patients were excluded: 207 patients without diagnostic ERCP data, 11 patients without preoperative CT data, 14 patients who had already un-dergone a cholecystectomy, 1 patient with a biliary tumor, and 2 patients who underwent MRCP more than once during the study period ( Fig. 1 ).
Finally, a total of 78 patients were included in this study. All patients underwent a preoperative or preprocedural MRCP, CT, and subsequent ERCP. (Table 1) .
MRCP without Enhancement Techniques
CT Techniques
All CT scans at our institution were obtained using a 64-channel CT scanner (GE discovery CT 750, GE healthcare, Chicago, IL, USA) with the following parameters: section thickness of 3. 
Imaging Analysis
Two radiologists (one with 7 years of experience and another with 13 years of experience in hepatobiliary imaging) independently and retrospectively reviewed CT and MRCP images according to predetermined uniform criteria, at a picture archiving We didn't review raw data of MRCP images in every patient because some MRCP protocol did not included raw data. For the purpose of the pathology report, one pathologist analyzed the resected surgical specimen after cholecystectomy.
Statistical Analysis
All the statistical analyses were performed using Medcalc ® 7.4.1.0 (MedCalc Software, Mariakerke, Belgium) and SPSS 14.0 
RESULTS
Clinical Data of the Study Population
Characteristics of the 78 patient participants are listed in Table 2 .
The mean age of the study population was 66.06 ± 15.63 years (range, 21-94 years); 31 men and 47 women were included. The mean interval between MRCP and ERCP was 1.63 ± 2.82 days (range, 0-13 days). The mean interval between CT and ERCP was 5.70 ± 10.98 days (range, 0-85 days) and that between CT and MRCP was 4.08 ± 10.44 days (range, 0-83 days).
Comparison of Diagnostic Performance between CT and MRCP for the Detection of Choledocholithiasis and Cholelithiasis
The diagnostic performance of CT and MRCP for the detection of choledocholithiasis is presented in Table 3 . The sensitivity of MRCP was determined to be significantly higher than the sensitivity of CT by both reviewers (73.3-75% vs. 50%, p < 0.001).
Both MRCP and CT modalities showed no significant differences in specificity; however, the accuracy of MRCP was significantly higher than the accuracy of CT (73.1-76.9% vs. 56.4-59%, p = 0.01). Both reviewers showed high positive predictive value For reviewer 1, 44 cases displayed true-positive results with MRCP, 16 cases showed true-negative findings, 2 cases showed false-positive findings, and 16 cases showed false-negative findings. For reviewer 2, 45 cases showed true-positive results with MRCP, 12 cases showed true-negative findings, 6 cases showed false-positive findings, and 15 cases showed false-negative findings. The representation of a true-positive case by both reviewers is shown in Fig. 2 . A false-positive case and false-negative case are shown in Figs. 3, 4 , respectively.
The diagnostic performance of CT and MRCP for the detection of cholelithiasis is shown in Table 4 . The sensitivity of MRCP was significantly higher than those of CT by reviewer 2 (97.7% Table 2 vs. 81.4%, p = 0.016), however the specificity and overall accuracy of CT and MRCP showed no significant difference by both two reviewers (p > 0.05).
. Characteristics of Study Population
Characteristics of Patients (n = 78)
Pathologic Results
Among 78 patients, 43 underwent cholecystectomy. Chronic cholecystitis was the most frequent pathology, found in 24 cases, followed by acute cholecystitis, found in 11 cases. The remaining eight cases consisted of two cases of acute on chronic cholecystitis, two cases of xanthogranulomatous cholecystitis, one case of subacute cholecystitis and three miscellaneous cases of gallbladder polyp, cholesterolosis and carcinoid tumor. Previous studies have confirmed the high diagnostic accuracy of MRCP, which is superior to US or CT (1, (8) (9) (10) (11) . Although the recent meta-analysis reported high specificity (95%) (1) , several other studies reported lower specificity (83.3-88%) of MRCP which is similar to our study (12, 13) . The specificity of MRCP was not superior to that of CT because CT is relatively specific for the detection of CBD stones. MRCP and CT show comparable specificity not only in previous studies (5, 12) , but also in this study.
Therefore, we recommend MRCP as a first-line modality for the detection of CBD stones in patients with suspected chole- However, MRCP is not specific and cannot guarantee the absence of CBD stones. The specificity of MRCP may limit indications for the detection of small stones less than 5 mm in size (14, 15) . Occasionally, there are false-positives and false-negatives. Factors that contribute to false-positive results may include flow artifacts, blood clots, air bubbles, and vascular structures such as the right pancreaticoduodenal artery (16) . Two false-positive cases were identified by reviewer 1 and six falsepositive cases were identified by reviewer 2, with flow artifact as a contributing influence. To differentiate flow artifact within the tortuous CBD from true CBD sludge, reexamine spin echo sequences using a refocusing 180 pulse additional to HASTE sequence would be recommended; this ensures persistent filling defects seen in the CBD. Spontaneous stone migration during the interval between MRCP and ERCP may also occur (12, 17) .
In this study, the mean interval between MRCP and ERCP was only 1-2 days. However, some patients experienced a delay of more than 10 days; the possibility of spontaneous migration of biliary stones for patients with longer intervals between MRCP and ERCP cannot be excluded.
MRCP showed high PPV (88.2-95.7%) but low NPV (44.4-50%) in our study, indicating that there were considerable false negatives in both reviewers. As mentioned previously, small sludge occurrences, stones less than 5 mm in diameter, and nondilated CBD less than 8 mm in diameter are potential causes of false-negative results (3, 18) . Endoscopic ultrasound (EUS) may be recommended as a second-line modality in cases of negative CBD stones using MRCP in order to rule out small stones (8) .
Although several studies comparing EUS and MRCP showed no significant differences between the two modalities in diagnostic performance (19) , EUS represents better accuracy in detecting small biliary stones (< 5 mm) (11) . A recent study has demonstrated that calculi smaller than 5 mm may be under-diagnosed in MRCP; nevertheless, MRCP is highly sensitive for the diagnosis of bile duct calculi larger than 5 mm (20) . EUS is an invasive and operator-dependent procedure; therefore, inadequate visualization of CBD could be limitations. In addition, EUS is technically demanding in severely ill patients and cannot be performed in patients with altered gastroduodenal anatomy (12) . Intraoperative cholangiography (IOC) is another alternative procedure for MRCP. IOC can detect residual CBD stones after endoscopic treatment and prevent biliary tract injury during cholecystectomy (21) . However, additional IOC with chole- This study had some limitations. First, it was a retrospective study; therefore, the MRCP protocol was heterogeneous. MRCP performed early in the study period is limited by only two or three sequences which include T2-weighted HASTE image and single-shot thick slab image. However, these were instrumental sequences for imaging analysis. Although the CT protocol was also heterogeneous, all the CT exams included unenhanced scans, which were substantial for stone evaluation. Second, the mean interval of CT-ERCP and CT-MRCP was approximately 4-6 days; however, some cases exceeded 80 days between diagjksronline.org J Korean Soc Radiol 2018;78(3):147-156 nostic procedures. Therefore, CBD stones could be passed spontaneously between CT-MRCP or CT-ERCP intervals and can alter diagnostic performance. Third, imaging analysis of CT and MRCP were performed in the same day for several cases; therefore, bias may be present in the image interpretation. However, both reviewers analyzed images according to the predetermined criteria for CBD stones in CT and MRCP. Fourth, the entire study population did not undergo cholecystectomy. However, ERCP, the reference standard, was performed for all patients.
In conclusion, limited protocol MRCP without enhancement represented better diagnostic performance for choledocholithiasis than CT with reliable interobserver agreement. Considering the absence of radiation and contrast media, MRCP is appropriate for a first-line preoperative modality in evaluation of CBD stone in patients with suspected cholecystitis.
